Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for extensive chronic graft-versus-host disease after allogeneic stem cell transplantation
2004-004819-29Phase 2Completed
- Sponsor
- University of Udine
- Start
- Aug 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of rituximab in chronic graft-versus-host disease (cGVHD), sponsored by University of Udine. Started Aug 2005; status: completed.
02
Drugs
rituximab
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on 2004-004819-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004819-29.